tykhr
sign in
free sign up
Fusion Pharmaceuticals Inc
Biotechnology
Healthcare
FUSN
66.28 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
9.60
52 week high
9.65
high
9.61
52 week low
2.35
low
8.05
growth
112.31 %
previous Close
9.61
P/E ratio
market cap
203 M
div yield
0
usd
Jun 2023
qoq
revenue
34.00 K
21.43 %
net incoming
-25.18 M
-3.64 %
eps
0.00 %
15.56 %
eps surprise
2.56 %
net profit margin
-74044.12 %
12709.00 %
operating incoming
-26.71 M
-7.48 %
net change in cash
-21.60 M
-326.08 %
cash on hand
32.02 M
-40.28 %
cost of revenue
0.00 %
top